Skip to content
Home/Companies/Pharma/Immedica

Immedica

Pharma·Sweden·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Immedica?

Immedica is currently owned by Impilo through Impilo Investment Pool 1 (2018 vintage), since 2018.

Hand-verified · updated 2026-08-17

Impilo
Investor
Impilo
Impilo Investment Pool 1 · 2018 · Buyout

Key facts

HQSweden
SectorPharma
StatusActive

More from Impilo Investment Pool 1

Other portfolio companies in the same fund.

Euro Accident
Active
FinancialsSweden· 2019
Humana
Active
HealthcareSweden· 2019
TFP Fertility
Exited 2024
HealthcareUK· 2019
to
Cavidi
Exited 2020
MedTechSweden· 2018
to
Ferrosan Medical Devices
Exited 2024
MedTechDenmark· 2017
to
NutraQ
Exited 2021
ConsumerNorway· 2017
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Immedica

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Immedica?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Immedica.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue